Amcare Biosciences

Our Products

CefuBees-CV 625 | Cefuroxime 500 mg + Clavulanic Acid 125 mg

CefuBees-CV 625

Product Composition

Manufacturer of Each film coated tablet contains : Cefuroxime Axetil 500 mg + Potassium Clavulanate 125 mg

Packaging Details

10 X1 X 10 ALU-ALU

Product Description

CefuBees-CV 625 – Cefuroxime Axetil 500 mg + Clavulanic Acid 125 mg Tablets

CefuBees-CV 625 by Amcare Pharmaceuticals is a prescription antibacterial combination containing Cefuroxime Axetil equivalent to Cefuroxime 500 mg and Potassium Clavulanate equivalent to Clavulanic Acid 125 mg per film-coated tablet.

CefuBees-CV 625 Composition

Each film-coated tablet contains:

  • Cefuroxime Axetil IP equivalent to Cefuroxime – 500 mg
  • Potassium Clavulanate Diluted IP equivalent to Clavulanic Acid – 125 mg
  • Excipients – q.s.
  • Colour – Titanium Dioxide IP

Product Details

Parameter Details
Brand Name CefuBees-CV 625
Generic Name Cefuroxime Axetil + Clavulanic Acid
Strength 500 mg + 125 mg
Dosage Form Film-Coated Tablets
Route Oral
Category Prescription Antibacterial
Pack Size 10 × 1 × 10 Tablets
Company Amcare Pharmaceuticals

CefuBees-CV 625 Uses

CefuBees-CV 625 may be prescribed by a healthcare professional for susceptible bacterial infections where this combination is considered appropriate. Cefuroxime is used for several bacterial respiratory, ear, sinus, skin and urinary infections.

It should not be used for viral infections such as common cold or influenza.

CefuBees-CV 625 Benefits

  • Contains Cefuroxime equivalent to 500 mg
  • Contains Clavulanic Acid equivalent to 125 mg
  • Combines a cephalosporin antibacterial with a beta-lactamase inhibitor
  • Film-coated tablet for convenient oral administration
  • Available in a 10 × 1 × 10 tablet pack

How Does CefuBees-CV 625 Work?

Cefuroxime in CefuBees-CV 625

Cefuroxime is a cephalosporin antibacterial that works by inhibiting bacterial cell-wall synthesis, leading to destruction of susceptible bacteria.

Clavulanic Acid in CefuBees-CV 625

Clavulanic acid is a beta-lactamase inhibitor. Its role in combination formulations is to inhibit certain beta-lactamase enzymes that can reduce the activity of beta-lactam antibiotics.

CefuBees-CV 625 Dosage and Administration

The dosage and duration should be determined by the prescribing healthcare professional according to the infection, patient characteristics and clinical response.

  • Take exactly as prescribed.
  • Do not skip doses or stop the course without medical advice.
  • Do not use antibiotics without appropriate medical guidance.
  • Patients with kidney impairment may require individualized dosing.

CefuBees-CV 625 Side Effects

Possible side effects may include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal discomfort
  • Headache
  • Dizziness
  • Skin rash

Seek urgent medical attention for signs of a serious allergic reaction or severe/persistent diarrhea.

CefuBees-CV 625 Precautions and Warnings

Tell your doctor if you:

  • Have an allergy to cefuroxime, cephalosporins, penicillins or other beta-lactam antibiotics.
  • Have kidney problems.
  • Have previously experienced severe antibiotic-associated diarrhea.
  • Are taking other medicines.
  • Are pregnant or breastfeeding.

Cefuroxime should be used only for infections that are proven or strongly suspected to be caused by susceptible bacteria.

CefuBees-CV 625 Storage

  • Store in a cool, dry place.
  • Protect from moisture, excessive heat and direct sunlight.
  • Keep out of reach of children.
  • Keep tablets in the original packaging.

Why Choose CefuBees-CV 625 by Amcare Pharmaceuticals?

CefuBees-CV 625 by Amcare Pharmaceuticals provides a combination formulation of Cefuroxime and Clavulanic Acid in a convenient film-coated tablet dosage form for prescription use.

CefuBees-CV 625 | Cefuroxime 500 mg + Clavulanic Acid 125 mg

59, Tulsi Estate & Plaza,
Besides Changodar Bridge, Changodar, Ahmedabad-382213.

+91 99139 17125

info.amcerebiosciences@gmail.com

Get in touch with us